Macrogenics (MGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -66,966 | -51,545 | -107,854 | -52,190 | -9,058 |
| Depreciation Amortization | 4,730 | 2,862 | 1,398 | 526 | 4,641 |
| Accounts receivable | 6,058 | 1,616 | 4,176 | 3,148 | 45,855 |
| Accounts payable and accrued liabilities | -1,530 | 170 | -1,243 | 4,179 | 1,281 |
| Other Working Capital | 1,392 | -1,237 | 2,875 | -149 | 53,316 |
| Other Operating Activity | -12,057 | 18,168 | 10,520 | -1,157 | -174,240 |
| Operating Cash Flow | $-68,373 | $-29,966 | $-90,128 | $-45,643 | $-78,205 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 112,843 | 110,756 | 74,645 | 26,253 | -78,384 |
| PPE Investments | -3,546 | -2,926 | -2,414 | -1,459 | -1,700 |
| Other Investing Activity | 40,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $149,297 | $107,830 | $72,231 | $24,794 | $-80,084 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,435 | 3,276 | 3,270 | 2,639 | 1,169 |
| Other Financing Activity | -2,475 | -2,471 | -2,397 | -2,391 | 149,192 |
| Financing Cash Flow | $960 | $805 | $873 | $248 | $150,361 |
| Beginning Cash Position | 100,956 | 100,956 | 100,956 | 100,956 | 108,884 |
| End Cash Position | 182,840 | 179,625 | 83,932 | 80,355 | 100,956 |
| Net Cash Flow | $81,884 | $78,669 | $-17,024 | $-20,601 | $-7,928 |
| Free Cash Flow | |||||
| Operating Cash Flow | -68,373 | -29,966 | -90,128 | -45,643 | -78,205 |
| Capital Expenditure | -3,706 | -3,086 | -2,494 | -1,459 | -1,764 |
| Free Cash Flow | -72,079 | -33,052 | -92,622 | -47,102 | -79,969 |